African-American Men with Gleason Score 3+3=6 Prostate Cancer Produce Less Prostate Specific Antigen than Caucasian Men: A Potential Impact on Active Surveillance

Journal of Urology

Volumn 195, Issue 2, 2016, Pages 301-306

  Kryvenko, Oleksandr N ^a   Balise, Raymond ^a   Soodana Prakash, Nachiketh ^a   Epstein, Jonathan I ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

African Americans; European continental ancestry group; neoplasm grading; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; ARTICLE; BODY MASS; CAUCASIAN; CONTROLLED STUDY; DISEASE SURVEILLANCE; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; TUMOR VOLUME; BLOOD; CANCER GRADING; COMPARATIVE STUDY; ETHNOLOGY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PROSTATIC NEOPLASMS; UNITED STATES;

AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; ORGAN SIZE; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TUMOR BURDEN; UNITED STATES;

EID: 84953840319     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2015.08.089     Document Type: Article

References (30)

1. H.B. Carter, P.C. Albertsen, M.J. Barry, and et al. Early detection of prostate cancer: AUA guideline J Urol 190 2013 419
2. J.I. Epstein, P.C. Walsh, M. Carmichael, and et al. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer JAMA 271 1994 368
3. O.N. Kryvenko, H.B. Carter, B.J. Trock, and et al. Biopsy criteria for determining appropriateness for active surveillance in the modern era Urology 83 2014 869
4. J. Mohler, R.R. Bahnson, B. Boston, and et al. NCCN clinical practice guidelines in oncology: prostate cancer J Natl Compr Canc Netw 8 2010 162
5. J.I. Epstein, W.C. Allsbrook Jr., M.B. Amin, and et al. The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma Am J Surg Pathol 29 2005 1228
6. D. Sundi, O.N. Kryvenko, H.B. Carter, and et al. Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men J Urol 191 2014 60
7. M.B. Amin, D.W. Lin, J.L. Gore, and et al. The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation Arch Pathol Lab Med 138 2014 1387
8. J.E. Fowler Jr., S.A. Bigler, N.K. Kilambi, and et al. Relationships between prostate-specific antigen and prostate volume in black and white men with benign prostate biopsies Urology 53 1999 1175
9. R.J. Henderson, J.A. Eastham, D.J. Culkin, and et al. Prostate-specific antigen (PSA) and PSA density: racial differences in men without prostate cancer J Natl Cancer Inst 89 1997 134
10. M. Tsivian, L.L. Bañez, C.J. Keto, and et al. African-American men with low-grade prostate cancer have higher tumor burdens: results from the Duke Prostate Center Prostate Cancer Prostatic Dis 16 2013 91
11. Epstein JI, Egevad L, Amin MB, et al. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Unpublished data.
12. O.N. Kryvenko, and J.I. Epstein Re: Nationwide prevalence of lymph node metastases in Gleason score 3 + 3 = 6 prostate cancer Pathology 47 2015 394
13. H.M. Ross, O.N. Kryvenko, J.E. Cowan, and et al. Do adenocarcinomas of the prostate with Gleason score (GS)
14. A.W. Partin, H.B. Carter, D.W. Chan, and et al. Prostate specific antigen in the staging of localized prostate cancer: influence of tumor differentiation, tumor volume and benign hyperplasia J Urol 143 1990 747
15. G.P. Swanson, J.I. Epstein, C.S. Ha, and et al. Pathological characteristics of low risk prostate cancer based on totally embedded prostatectomy specimens Prostate 75 2015 424
16. H. Samaratunga, R. Montironi, L. True, and et al. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling Mod Pathol 24 2011 6
17. G.A. Tjionas, J.I. Epstein, S.R. Williamson, and et al. Average weight of seminal vesicles: an adjustment factor for radical prostatectomy specimens weighed with seminal vesicles Int J Surg Pathol 2015 Epub ahead of print
18. O.N. Kryvenko, J.I. Epstein, F.A. Meier, and et al. Correlation of high body mass index with more advanced localized prostate cancer at radical prostatectomy is not reflected in PSA level and PSA density but is seen in PSA mass Am J Clin Pathol 144 2015 271
19. T.O. Morgan, S.J. Jacobsen, W.F. McCarthy, and et al. Age-specific reference ranges for prostate-specific antigen in black men N Engl J Med 335 1996 304
20. E.P. DeAntoni, E.D. Crawford, J.E. Oesterling, and et al. Age- and race-specific reference ranges for prostate-specific antigen from a large community-based study Urology 48 1996 234
21. I. Abdalla, P. Ray, V. Ray, and et al. Comparison of serum prostate-specific antigen levels and PSA density in African-American, white, and Hispanic men without prostate cancer Urology 51 1998 300
22. J.C. Presti Jr., R. Hovey, V. Bhargava, and et al. Prospective evaluation of prostate specific antigen and prostate specific antigen density in the detection of carcinoma of the prostate: ethnic variations J Urol 157 1997 907
23. J.W. Moul, I.A. Sesterhenn, R.R. Connelly, and et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men JAMA 274 1995 1277
24. S. Vijayakumar, T. Karrison, R.R. Weichselbaum, and et al. Racial differences in prostate-specific antigen levels in patients with local-regional prostate cancer Cancer Epidemiol Biomarkers Prev 1 1992 541
25. J.W. Moul, R.R. Connelly, R.M. Mooneyhan, and et al. Racial differences in tumor volume and prostate specific antigen among radical prostatectomy patients J Urol 162 1999 394
26. R.F. Sanchez-Ortiz, P. Troncoso, R.J. Babaian, and et al. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men Cancer 107 2006 75
27. M. Varma, and J.M. Morgan The weight of the prostate gland is an excellent surrogate for gland volume Histopathology 57 2010 55
28. C.W. Jeong, H.K. Park, S.K. Hong, and et al. Comparison of prostate volume measured by transrectal ultrasonography and MRI with the actual prostate volume measured after radical prostatectomy Urol Int 81 2008 179
29. R.B. D'Agostino Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group Stat Med 17 1998 2265
30. P.R. Rosenbaum, and D.B. Rubin The central role of the propensity score in observational studies for causal effects Biometrika 70 1983 41